Tolerance and Activity Evaluation of High Doses of Favipiravir Against Ebola Virus in the Semen
Status:
Terminated
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
This study aims to evaluate favipiravir high dose tolerance in male survivor of Ebola Virus
Disease (EVD) with Ebola Virus (EBOV) RNA in semen. This is a dose escalation study with 3
cohorts of 6 patients, each dose level including 2 sentinel patients.